Epidemiology of Guillain-Barré Syndrome and Risk Associated with Exposure to ABRYSVO Among Vaccinees 18-59 Years of Age in the United States First published 27/06/2025 Last updated 01/08/2025 EU PAS number:EUPAS1000000629 Study Ongoing